Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00733993 · ClinicalTrials.gov registry record · Phase 1

Caffeine and Cocaine

A Phase 1 study of Cocaine Dependence, sponsored by Virginia Commonwealth University.

Completed
Registry status
Phase 1
Development phase
23
Enrollment target
1
Study location

NCT00733993 is a Phase 1 study of Cocaine Dependence that has completed, run by Virginia Commonwealth University. The registered enrollment target is 23 participants, below the 298-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00733993, a Phase 1 study of Cocaine Dependence, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
Phase 1
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This study is being done to find out if medicines that affect a neurotransmitter (chemical messenger) in the brain called adenosine improve behavioral problems that are related to drug abuse. Another purpose of the study is to find out how genes related to adenosine change how people respond to these medicines. More information about how these medicines change behaviors may be helpful to come up with new treatments for drug abuse.

Conditions Studied

Cocaine Dependence

Interventions

  • DRUG Placebo
  • DRUG Amphetamine
  • DRUG Caffeine 150 MG
  • DRUG Caffeine 300 MG

Study Locations (1)

Texas

  • The University of Texas Health Science Center, Houston - Houston

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2008-04
Est. Completion 2011-10
Phase Phase 1

Sponsor

Virginia Commonwealth University

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00733993

The ClinicalTrials.gov registry entry for NCT00733993 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 298-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (92% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT00733993 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00733993 about?

NCT00733993 is a clinical study titled "Caffeine and Cocaine". This study is being done to find out if medicines that affect a neurotransmitter (chemical messenger) in the brain called adenosine improve behavioral problems that are related to drug abuse. Another purpose of the study is to find out how genes related to adenosine change how people respond to thes...

What is the current status of trial NCT00733993?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2008-04. Estimated completion is 2011-10.

What conditions does trial NCT00733993 study?

This clinical trial studies the following conditions: Cocaine Dependence.

What interventions are being tested in trial NCT00733993?

The interventions under investigation include: Placebo (DRUG), Amphetamine (DRUG), Caffeine 150 MG (DRUG), Caffeine 300 MG (DRUG).

Who is sponsoring clinical trial NCT00733993?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00733993 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cocaine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cocaine Dependence

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.